Immune impairment and metastatic tumor growth. The need for an immunorestorative drug as an adjunct to surgery

Joel Lundy; Edmund J. Lovett; Steven M. Wolinsky; Philip Conran

doi:10.1002/1097-0142(197903)43:3<945::AID-CNCR2820430324>3.0.CO;2-V

Immune impairment and metastatic tumor growth. The need for an immunorestorative drug as an adjunct to surgery

Joel Lundy^*, Edmund J. Lovett, Steven M. Wolinsky, Philip Conran

^*Corresponding author for this work

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Abstract

A spontaneous murine metastatic tumor system was used as a model to assess the effects of a major surgical procedure on tumor‐specific immune reactivity and the growth of micrometastases. Any major surgical procedure resulted in impaired cell‐mediated cytotoxicity postoperatively and an increase in the number of gross pulmonary metastases. The use of an immunorestorative drug, Thiabendazole, in the perioperative period resulted in an improved cytotoxic response and a significant decrease in pulmonary metastases. Perioperative immunotherapy can be an effective adjunct to surgery in preventing the growth of micrometastatic foci. Cancer 43:945–951, 1979.

Original language	English (US)
Pages (from-to)	945-951
Number of pages	7
Journal	Cancer
Volume	43
Issue number	3
DOIs	https://doi.org/10.1002/1097-0142(197903)43:3<945::AID-CNCR2820430324>3.0.CO;2-V
State	Published - Mar 1979

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/1097-0142(197903)43:3<945::AID-CNCR2820430324>3.0.CO;2-V

Fingerprint Dive into the research topics of 'Immune impairment and metastatic tumor growth. The need for an immunorestorative drug as an adjunct to surgery'. Together they form a unique fingerprint.

Cite this

@article{b437fe0065024a16a87bca844a3155cc,

title = "Immune impairment and metastatic tumor growth. The need for an immunorestorative drug as an adjunct to surgery",

abstract = "A spontaneous murine metastatic tumor system was used as a model to assess the effects of a major surgical procedure on tumor‐specific immune reactivity and the growth of micrometastases. Any major surgical procedure resulted in impaired cell‐mediated cytotoxicity postoperatively and an increase in the number of gross pulmonary metastases. The use of an immunorestorative drug, Thiabendazole, in the perioperative period resulted in an improved cytotoxic response and a significant decrease in pulmonary metastases. Perioperative immunotherapy can be an effective adjunct to surgery in preventing the growth of micrometastatic foci. Cancer 43:945–951, 1979.",

author = "Joel Lundy and Lovett, {Edmund J.} and Wolinsky, {Steven M.} and Philip Conran",

year = "1979",

month = mar,

doi = "10.1002/1097-0142(197903)43:3<945::AID-CNCR2820430324>3.0.CO;2-V",

language = "English (US)",

volume = "43",

pages = "945--951",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Immune impairment and metastatic tumor growth. The need for an immunorestorative drug as an adjunct to surgery

AU - Lundy, Joel

AU - Lovett, Edmund J.

AU - Wolinsky, Steven M.

AU - Conran, Philip

PY - 1979/3

Y1 - 1979/3

N2 - A spontaneous murine metastatic tumor system was used as a model to assess the effects of a major surgical procedure on tumor‐specific immune reactivity and the growth of micrometastases. Any major surgical procedure resulted in impaired cell‐mediated cytotoxicity postoperatively and an increase in the number of gross pulmonary metastases. The use of an immunorestorative drug, Thiabendazole, in the perioperative period resulted in an improved cytotoxic response and a significant decrease in pulmonary metastases. Perioperative immunotherapy can be an effective adjunct to surgery in preventing the growth of micrometastatic foci. Cancer 43:945–951, 1979.

AB - A spontaneous murine metastatic tumor system was used as a model to assess the effects of a major surgical procedure on tumor‐specific immune reactivity and the growth of micrometastases. Any major surgical procedure resulted in impaired cell‐mediated cytotoxicity postoperatively and an increase in the number of gross pulmonary metastases. The use of an immunorestorative drug, Thiabendazole, in the perioperative period resulted in an improved cytotoxic response and a significant decrease in pulmonary metastases. Perioperative immunotherapy can be an effective adjunct to surgery in preventing the growth of micrometastatic foci. Cancer 43:945–951, 1979.

UR - http://www.scopus.com/inward/record.url?scp=0018774702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018774702&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197903)43:3<945::AID-CNCR2820430324>3.0.CO;2-V

DO - 10.1002/1097-0142(197903)43:3<945::AID-CNCR2820430324>3.0.CO;2-V

M3 - Article

C2 - 427734

AN - SCOPUS:0018774702

VL - 43

SP - 945

EP - 951

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -

Immune impairment and metastatic tumor growth. The need for an immunorestorative drug as an adjunct to surgery

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this